Press release
2025 Epigenetics Diagnostics Market Outlook: Key Indicators Shaping Growth Through 2034
Epigenetics Diagnostics Market
What Will the Epigenetics Diagnostics Industry Market Size Be by 2025?
In recent times, the size of the epigenetics diagnostics market has shown swift expansion. It is projected to escalate from $14.20 billion in 2024 to $16.56 billion in 2025, marking a compound annual growth rate (CAGR) of 16.6%. Factors propelling this upward trend from the historic period include heightened funding for epigenetic research, the expansion of government initiatives, growing elderly population, increasing neurological disorders, and a surge in the number of clinical trials.
What's the Long-Term Growth Forecast for the Epigenetics Diagnostics Market Size Through 2029?
Anticipated to experience a swift expansion in the upcoming years, the epigenetics diagnostics market size is predicted to augment to $30.29 billion by 2029, with a compound annual growth rate (CAGR) of 16.3%. This surge during the projected period can be accredited to the escalating demand for individualized and precision medication, multiplying requests for liquid biopsy procedures, and the rising need for non-invasive diagnostic tactics. Significant trends during this forecast timeline encompass technological progressions, advancements in liquid biopsy, whole-genome bisulfite sequencing, the application of deep learning for biomarker discovery, and the incorporation with personalized medicine.
View the full report here:
https://www.thebusinessresearchcompany.com/report/epigenetics-diagnostics-global-market-report
What Are the Key Growth Drivers Fueling the Epigenetics Diagnostics Market Expansion?
The surge in demand for tailor-made medical interventions is set to stimulate the expansion of the epigenetics diagnostics market. This demand emanates from the evolution of personalized medicine, an approach that adapts medical care to the genetic composition, biological factors, and lifestyle conditions of an individual. The escalation of this demand is a result of progress in genetic and molecular identification, which provides the foundation for treatments that are specifically programmed for a person's biological design, thus enhancing efficacy and curbing side effects. Epigenetics diagnostics enhances personalized medicine by pinpointing unique epigenetic models, directing bespoke preventative procedures and treatment blueprints for ideal patient results. For example, in February 2024, as cited by the Personalized Medicine Coalition, a non-profit based in the United States, 16 new personalized therapies for patients suffering from rare illnesses were sanctioned by the FDA in 2023, a significant increase from six in 2022. Therefore, the booming demand for personalized medicine is fuelling the ascend of the epigenetics diagnostics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27286&type=smp
What Are the Key Trends Driving Epigenetics Diagnostics Market Growth?
Major corporations in the field of epigenetics diagnostics are concentrating on devising innovative strategies including the implementation of clinical-grade epigenetic analysis to improve precision, sensitivity, and functional value of disease-related epigenetic modification detection. Clinical-grade epigenetic analysis is a practice whereby validated and standardized procedures are utilized to identify epigenetic alternations with the precision and trustworthiness necessary for clinical diagnostics and therapeutic decisions. In particular, in October 2024, EpiMedTech, a bio-tech firm based in Singapore, unveiled epiGeneComplete, a clinical-grade examination that combines genetic and epigenetic analysis implementing next-generation sequencing and sophisticated DNA methylation methods to provide in-depth understanding of crucial health determinants such as aging, stress, inflammation, susceptibility to addiction, and metabolism. This non-invasive, saliva-based test conducted in CAP-accredited labs, not only provides a high level of sensitivity and accuracy but also promotes personalized health profiling and is capable of accommodating future diagnostic enhancements. This signifies a noteworthy progression in routine health monitoring and early disease detection.
How Is the Epigenetics Diagnostics Market Segmented?
The epigenetics diagnostics market covered in this report is segmented
1) By Product: Kits And Reagents, Software And Services, Instruments
2) By Technology: Deoxyribonucleic Acid (DNA) Methylation, Histone Methylation, Histone Acetylation, Large NonCoding, Ribonucleic Acid (RNA), Micro Ribonucleic Acid (RNA) Modification, Chromatin Structures
3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications
4) By End User: Pharmaceutical And Biotechnology firms, Academic And Research Institutes, Clinical Diagnostic Laboratories
Subsegments:
1) By Kits and Reagents: Deoxyribonucleic Acid Methylation Kits, Histone Modification Kits, Chromatin Accessibility Kits, Bisulfite Conversion Kits, Polymerase Chain Reaction Reagents, Antibodies and Probes, Enzymes and Buffers
2) By Software and Services: Data Analysis Software, Bioinformatics Services, Epigenetic Data Interpretation, Cloud-based Data Storage, Custom Assay Development, Validation and Consulting Services
3) By Instruments: Next-Generation Sequencers, Microarray Systems, Polymerase Chain Reaction and Quantitative Polymerase Chain Reaction Instruments, Mass Spectrometry Systems, Imaging Systems, Automation and Liquid Handling Systems
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27286&type=smp
Which Companies Are Leading the Charge in Epigenetics Diagnostics Market Innovation?
Major companies operating in the epigenetics diagnostics market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., GeneTex Inc., Bio-Techne Corporation, Promega Corporation, New England Biolabs Incorporated, Pacific Biosciences of California Inc., Enzo Biochem Inc., Diagenode Société Anonyme, Zymo Research Corporation, Active Motif Inc., ADmit Therapeutics SL, Epigentek Group Inc., and INHERENT Biosciences Inc.
Which Regions Are Leading the Global Epigenetics Diagnostics Market in Revenue?
North America was the largest region in the epigenetics diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epigenetics diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27286
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025 Epigenetics Diagnostics Market Outlook: Key Indicators Shaping Growth Through 2034 here
News-ID: 4171090 • Views: …
More Releases from The Business research company
Gene Therapy For Inherited Genetic Disorders Market Landscape 2025: Forecast Dat …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Gene Therapy For Inherited Genetic Disorders Market Through 2025?
In recent years, there has been swift growth in the market size for gene therapy for inherited genetic disorders. An increase from $3.39 billion in 2024 to $4.05 billion in 2025, corresponding to…
Growing Emphasis On Personalized Medicine Fueling The Growth Of The Market Due T …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the T Cell Specific Surface Glycoprotein CD28 Market Size By 2025?
In recent times, the market for the T cell-specific surface glycoprotein known as CD28 has expanded at a brisk pace. Forecasts suggest an increase from $1.47 billion in 2024 to approximately $1.62 billion in 2025,…
Driving Space Medicine Market Growth in 2025: The Role of Increasing Interest In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Space Medicine Market Size Growth Forecast: What to Expect by 2025?
Over the past few years, the size of the space medicine market has significantly increased. It is projected to rise from $1.18 billion in 2024 to $1.33 billion in 2025, showcasing a compound annual growth rate (CAGR) of…
Comprehensive Single Port Surgical Platforms Market Forecast 2025-2034: Growth T …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Single Port Surgical Platforms Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for single port surgical platforms has seen swift expansion in the recent past. A growth from $1.36 billion in 2024 to $1.54 billion in 2025 is projected, representing a compound…
More Releases for Epigenetic
Epigenetics Market - Harnessing the Epigenetic Revolution: Transforming the Futu …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Epigenetics Market.
Epigenetics Market: https://www.growthplusreports.com/report/epigenetics-market/9171
The Epigenetics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy. The Epigenetics market…
Epigenetic Market 2021 | Detailed Report
The Epigenetic research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the Epigenetic industry to…
Epigenetic Market major players New England Biolabs, Inc., Thermo Fisher Scienti …
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,…
Epigenetic Market Forecast By End-use Industry 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,…
Epigenetic Market to Observe Strong Development by 2016-2026
The epigenetic process includes phosphorylation, methylation, sumolyation, acetylation and ubiquitylation etc. of DNA as well as histones resulting in changes in Phenotypes. These changes are modified with environmental conditions. Epigenetic market is now an emerging field. There are various diagnostic tests available now that detect epigenetic changes. There are some FDA approved epigenetic drugs. Other than many diagnostic companies, many biopharmaceutical and pharmaceutical companies are also very active in the…
Epigenetic Market Plying for Significant Growth During 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,…
